Literature DB >> 6977492

Epithelioid granuloma induced by muramyl dipeptide in immunologically deficient rats.

S Nagao, F Ota, K Emori, K Inoue, A Tanaka.   

Abstract

When WKA rats were either neonatally thymectomized or injected with anti-rat thymocyte sera, their T-cell functions were effectively suppressed. When neonatally thymectomized plus anti-rat thymocyte serum-treated rats were injected with non-immunogenic muramyl dipeptide in water-in-oil emulsion, they produced massive epithelioid granulomas. Essentially, no morphological difference was noticed between granulomas induced in untreated rats and in thymectomized plus anti-rat thymocyte serum-treated rats. These findings strongly suggest that muramyl dipeptide-induced epithelioid granulomas required no T cells for their formation. In contrast, the induction of adjuvant arthritis appeared to depend on the presence of T cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6977492      PMCID: PMC350966          DOI: 10.1128/iai.34.3.993-999.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Passive transfer of unresponsiveness by lymph node cells. Studies on adjuvant disease.

Authors:  E M Eugui; R H Houssay
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

2.  The effect of neonatal and adult thymectomy on the inflammatory response.

Authors:  T L Rothwell; W G Spector
Journal:  J Pathol       Date:  1972-09       Impact factor: 7.996

Review 3.  Granulomatous hypersensitivity.

Authors:  W L Epstein
Journal:  Prog Allergy       Date:  1967

4.  Capacity of mycobacterial wax D and its subfractions to induce adjuvant arthritis in rats.

Authors:  F D Wood; C M Pearson; A Tanaka
Journal:  Int Arch Allergy Appl Immunol       Date:  1969

5.  Specific granulomatous hypersensitivity elicited by bentonite particles coated with soluble antigens from schistosome eggs and turcle bacilli.

Authors:  D L Boros; K S Warren
Journal:  Nature       Date:  1971-01-15       Impact factor: 49.962

6.  The origin, properties and fate of epithelioid cells.

Authors:  J M Papadimitriou; W G Spector
Journal:  J Pathol       Date:  1971-11       Impact factor: 7.996

7.  Animal experimental studies on chronic granulomatous inflammation and T-lymphocyte-system.

Authors:  B Heymer; H P Hobik; H Schäfer; B Bültmann; R Spanel; O Haferkamp
Journal:  Beitr Pathol       Date:  1975-11

8.  An experimental model of pulmonary arterial granulomatous inflammation.

Authors:  E J Kasdon; S F Schlossman
Journal:  Am J Pathol       Date:  1973-06       Impact factor: 4.307

9.  Immunologic events in experimental hypersensitivity granulomas.

Authors:  E R Unanue; B Benacerraf
Journal:  Am J Pathol       Date:  1973-06       Impact factor: 4.307

10.  Transformation of monocytes in tissue culture into macrophages, epithelioid cells, and multinucleated giant cells. An electron microscope study.

Authors:  J S Sutton; L Weiss
Journal:  J Cell Biol       Date:  1966-02       Impact factor: 10.539

View more
  4 in total

1.  Experimental subcutaneous granulomas in sheep with Dermatophilus-like microorganisms from porcine tonsil.

Authors:  E Momotani; S Inui; Y Ishikawa; R Azuma
Journal:  Mycopathologia       Date:  1985-09       Impact factor: 2.574

2.  Immunosuppression induced by talc granulomatosis in the rat.

Authors:  I Radić; I Vucak; J Milosević; A Marusić; S Vukicević; M Marusić
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

3.  Enhanced superoxide anion release from phagocytes by muramyl dipeptide or lipopolysaccharide.

Authors:  M Kaku; K Yagawa; S Nagao; A Tanaka
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

4.  Granuloma formation by muramyl dipeptide associated with branched fatty acids, a structure probably essential for tubercle formation by Mycobacterium tuberculosis.

Authors:  K Emori; S Nagao; N Shigematsu; S Kotani; M Tsujimoto; T Shiba; S Kusumoto; A Tanaka
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.